BORIS HAVKIN MD NPI 1609867696

NPI Details

Boris Havkin, MD is an urology in Melbourne, FL with 28 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. Boris Havkin, MD NPI is 1609867696. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: STATE UNIVERSITY OF NEW YORK DOWNSTATE MEDICAL CENTER
Graduation Year:1998

The provider's business location address is:

3021 W EAU GALLIE BLVD
MELBOURNE, FL
ZIP 32934-005
Phone: (321) 500-4545
Fax: (321) 425-4000

The NPI 1609867696 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The CLIA number assigned to this NPI record is 10D2114963 - physician office with a certificate type of Certificate of Waiver.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Unclassified drugs (HCPCS:J3490)
• Identification of organisms by genetic analysis, amplified probe technique (HCPCS:87150)
• Injection, onabotulinumtoxina, 1 unit (HCPCS:J0585)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Placement of hormone pellet under skin (HCPCS:11980)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, mitomycin, 5 mg (HCPCS:J9280)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Insertion of implant in urethra within prostate gland using an endoscope, each additional implant (HCPCS:52442)
• Injection, tobramycin sulfate, up to 80 mg (HCPCS:J3260)
• Irrigation and removal of multiple blood clots from bladder and urethra using an endoscope (HCPCS:52001)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Destruction of tissue of bladder, urethra, or surrounding glands using an endoscope (HCPCS:52214)
• Automated urinalysis test (HCPCS:81003)
• Instillation of anti-cancer drug into bladder (HCPCS:51720)
• Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm (HCPCS:52224)
• Complex measurement of pressure of urine flow in bladder with voiding pressure studies (HCPCS:51728)
• Insertion of device into abdomen with pressure and urine flow rate study (HCPCS:51797)
• Insertion of implant in urethra within prostate gland using an endoscope, 1 implant (HCPCS:52441)
• Crushing, fragmenting, and removal of bladder stones, less than 2.5 cm (HCPCS:52317)
• Biopsy of prostate gland (HCPCS:55700)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Electronic analysis of implanted neurostimulator generator with simple spinal cord or peripheral nerve stimulator programming (HCPCS:95971)
• Simple bladder irrigation and/or instillation (HCPCS:51700)
• Dilation of urethra using an endoscope (HCPCS:52281)
• Exam with injections of chemical for destruction of bladder using an endoscope (HCPCS:52287)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)

The enumeration date for this NPI number is 10/31/2005 and was last updated on 6/5/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.